Authors:
Bouabdallah, R
Stoppa, AM
Coso, D
Bardou, VJ
Blaise, D
Chabannon, C
Gastaut, JA
Maraninchi, D
Citation: R. Bouabdallah et al., Clinical outcome after front-line intensive sequential chemotherapy (ISC) in patients with aggressive non-Hodgkin's lymphoma and high-risk international prognostic index (IPI 3): Final analysis of survival in two consecutiveISC trials, ANN ONCOL, 12(4), 2001, pp. 513-517
Authors:
Bouabdallah, R
Abena, P
Chetaille, B
Aurran-Schleinitz, T
Sainty, D
Dubus, P
Arnoulet, C
Coso, D
Xerri, L
Gastaut, JA
Citation: R. Bouabdallah et al., True histiocytic lymphoma following B-acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms, BR J HAEM, 113(4), 2001, pp. 1047-1050
Authors:
Serratrice-de Roux, C
Coso, D
Bouabdallah, R
Serratrice, J
Disdier, P
Weiller, PJ
Citation: C. Serratrice-de Roux et al., Chronic lymphocytic leukemia and Hodgkin's disease. Clinicopathologic study of three cases with good prognosis, HAEMATOLOG, 85(8), 2000, pp. 878-879
Authors:
Bouabdallah, R
Coso, D
Costello, R
Bardou, VJ
Blaise, D
Xerri, L
Sainty, D
Maraninchi, D
Gastaut, JA
Citation: R. Bouabdallah et al., Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center, BONE MAR TR, 25(1), 2000, pp. 35-40
Authors:
Bouabdallah, R
Coso, D
Gonzague-Casabianca, L
Alzieu, C
Resbeut, M
Gastaut, JA
Citation: R. Bouabdallah et al., Safely and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients, LEUK RES, 24(6), 2000, pp. 491-495
Authors:
Coso, D
Costello, R
Cohen-Valensi, R
Sainty, D
Nezri, M
Gastaut, JA
Bouabdallah, R
Citation: D. Coso et al., Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy, ANN ONCOL, 10(3), 1999, pp. 362-363
Authors:
Bouabdallah, R
Stoppa, AM
Rossi, JF
Lepeu, G
Coso, D
Xerri, L
Ladaique, P
Chabannon, C
Blaise, D
Bardou, VJ
Alzieu, C
Gastaut, JA
Maraninchi, D
Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956
Authors:
Bouabdallah, R
Lefrere, F
Rose, C
Chaibi, P
Harousseau, JL
Vernant, JP
Castaigne, S
Bauduer, F
Zini, JM
Coso, D
Varet, B
Robert, J
Fenaux, P
Citation: R. Bouabdallah et al., A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients, LEUKEMIA, 13(10), 1999, pp. 1491-1496